Celularity INC (CELUW) — 10-Q Filings

All 10-Q filings from Celularity INC. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

Celularity's Revenue Plummets, Losses Mount Amid Liquidity Crisis — Nov 14, 2025 Risk: high
Celularity Inc. reported a significant decline in total net revenues for the nine months ended September 30, 2025, falling to $22.446 million from $36.088 milli
Celularity's Cash Dries Up Amidst Declining Sales, Mounting Debt — Aug 29, 2025 Risk: high
Celularity Inc. (CELUW) reported a net loss of $19.754 million for the three months ended March 31, 2025, a slight improvement from the $22.013 million net loss
Celularity Inc. Q3 2024 Update: Agreements and Financials — Dec 6, 2024 Risk: medium
Celularity Inc. reported its third-quarter financial results for the period ending September 30, 2024. The company's filing details various business activities,
Celularity Inc. Files Q2 2024 10-Q — Nov 7, 2024 Risk: medium
Celularity Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its business operations. Key
Celularity Inc. Q1 2024 Update: Forbearance and Employment Agreements — Oct 16, 2024 Risk: medium
Celularity Inc. reported its first quarter 2024 results, ending March 31, 2024. The company entered into a forbearance agreement on March 13, 2024, related to i

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX